APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes
RecruitingPhase 4
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * patient undergoing vitrectomy surgery * able to give informed consent Exclusion Criteria: * post-operative eyedrop regimens that include topical non steroidal anti-inflammatory medications * subjects with altered post-operative eyedrop schedule for enhanced inflammation control * documented allergy to atropine
About the study
The study will evaluate whether atropine eyedrops are beneficial when used after certain eye surgeries.
What is being tested
- Atropine 1% (drug)
Sponsor: University of California, San Francisco · Participants: 62 · Started: Mar 10, 2026
Contact the study team
- Jay Stewart, MD · Phone: 415-353-9635
Official record on ClinicalTrials.gov — NCT07434635
Locations in the U.S.
| California | University of California, San Francisco, San Francisco |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.